Novartis MS Drug Kesimpta Quick Out Of The Blocks

Strong Challenger To Roche's Ocrevus

Starting_Block
Rapid start for Kesimpta in the US • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Neurological

More from Therapy Areas